ECORNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
electroCore, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$7.63−0.22 (-2.80%)
Close on Oct 19, 2026
- Market cap
- $71.75K
- P/E (TTM)
- –
- Dividend yield
- –
electroCore, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | – | – | $6.59M | $6.07M | $5.68M | $4.99M | $4.67M | $4.04M | – | – |
| United Kingdom | – | – | – | – | – | – | $400.00K | $454.00K | $427.00K | $385.00K | $454.00K | $412.00K | – | – |
| Japan | – | – | – | – | – | – | $15.00K | $16.00K | $15.00K | $19.00K | $19.00K | $19.00K | – | – |
| Other Countries [Member] | – | – | – | – | – | – | $37.00K | $15.00K | $22.00K | $45.00K | $50.00K | $33.00K | – | – |
From the segment and revenue-disaggregation notes of electroCore's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.